OCA
CVS icon

OpenArc Corporate Advisory’s CVS Health CVS Stock Holding History

OpenArc Corporate Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
11,120
+5,022
+82% +$448K 0.01% 319
2026
Q1 		$438K Buy
6,098
+1,090
+22% +$84K 0.01% 484
2025
Q4 		$397K Buy
+5,008
New +$395K 0.01% 449

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

OpenArc Corporate Advisory's CVS Position: Q2 2026 in Review

OpenArc Corporate Advisory increased its CVS Health (CVS) stake by 82% in Q2 2026, buying an estimated $448K and bringing the position to 11,120 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #319.

OpenArc Corporate Advisory first reported a position in CVS in Q4 2025 and has held it in 3 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • OpenArc Corporate Advisory held 11,120 shares of CVS Health worth $1.15M as of Q2 2026.
  • OpenArc Corporate Advisory bought 5,022 CVS Health shares in Q2 2026, an estimated $448K.
  • CVS Health made up 0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #319 holding.
  • OpenArc Corporate Advisory first reported a position in CVS Health in Q4 2025 and has held it in 3 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.